InsiderTrades.com logo

IKT Insider Trading

Insider Ownership Percentage: 7.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Inhibikase Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Inhibikase Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Inhibikase Therapeutics Share Price & Price History

Current Price: $1.51
Price Change: ▲ Price Increase of +0.07 (4.86%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for IKT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Inhibikase Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/21/2024Arvind KushDirectorBuy145,000$1.37$198,650.00145,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Inhibikase Therapeutics (NYSE:IKT)

3.81% of Inhibikase Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IKT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Inhibikase Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Susquehanna International Group LLP45,605$74K0.0%-88.1%0.061%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC71,670$0.12M0.0%N/A0.096%Search for SEC Filing on Google Icon
11/14/2025ADAR1 Capital Management LLC5,247,603$8.50M0.8%+2.5%7.042%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets15,640$25K0.0%+70.3%0.021%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.3,273,339$5.30M0.0%+1.5%4.393%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.49,937$81K0.0%+74.7%0.067%Search for SEC Filing on Google Icon
11/3/2025New York State Common Retirement Fund47,900$78K0.0%-21.1%0.064%Search for SEC Filing on Google Icon
8/15/2025Perceptive Advisors LLC5,432,293$10.59M0.9%-8.3%7.307%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE19,216$37K0.0%-57.3%0.026%Search for SEC Filing on Google Icon
8/14/2025Commodore Capital LP5,397,488$10.53M0.7%+1.0%7.260%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.33,023$64K0.0%N/A0.044%Search for SEC Filing on Google Icon
8/13/2025Stonepine Capital Management LLC733,793$1.43M1.4%-19.8%0.987%Search for SEC Filing on Google Icon
8/13/2025Invesco Ltd.30,712$60K0.0%N/A0.041%Search for SEC Filing on Google Icon
8/13/2025New York State Common Retirement Fund60,700$0.12M0.0%N/A0.082%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.28,579$56K0.0%N/A0.038%Search for SEC Filing on Google Icon
8/8/2025Intech Investment Management LLC31,406$61K0.0%N/A0.042%Search for SEC Filing on Google Icon
8/8/2025Police & Firemen s Retirement System of New Jersey17,638$34K0.0%N/A0.024%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC1,066,700$2.08M0.0%+228.5%1.435%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.166,025$0.36M0.0%+277.7%0.223%Search for SEC Filing on Google Icon
5/19/2025Jane Street Group LLC116,249$0.26M0.0%N/A0.156%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.166,025$0.36M0.0%+277.7%0.223%Search for SEC Filing on Google Icon
5/16/2025ADAR1 Capital Management LLC5,122,105$11.22M2.1%+0.4%6.890%Search for SEC Filing on Google Icon
5/14/2025Stonepine Capital Management LLC914,973$2M1.9%-19.2%1.231%Search for SEC Filing on Google Icon
5/9/2025Blair William & Co. IL155,953$0.34M0.0%+15.6%0.210%Search for SEC Filing on Google Icon
5/6/2025Y Intercept Hong Kong Ltd26,775$59K0.0%N/A0.036%Search for SEC Filing on Google Icon
2/27/2025Jefferies Financial Group Inc.14,800$48K0.0%N/A0.021%Search for SEC Filing on Google Icon
2/18/2025Alpine Global Management LLC14,842$48K0.0%N/A0.021%Search for SEC Filing on Google Icon
2/17/2025Soleus Capital Management L.P.6,325,000$20.56M1.3%N/A9.119%Search for SEC Filing on Google Icon
2/17/2025Squarepoint Ops LLC28,411$92K0.0%N/A0.041%Search for SEC Filing on Google Icon
2/17/2025Stonepine Capital Management LLC1,132,388$3.68M3.0%N/A1.633%Search for SEC Filing on Google Icon
2/17/2025OMERS ADMINISTRATION Corp54,600$0.18M0.0%N/A0.079%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC142,209$0.46M0.0%N/A0.205%Search for SEC Filing on Google Icon
2/17/2025Jefferies Financial Group Inc.14,800$48K0.0%N/A0.021%Search for SEC Filing on Google Icon
2/17/2025Fairmount Funds Management LLC6,125,000$19.91M2.0%N/A8.831%Search for SEC Filing on Google Icon
2/17/2025Blackstone Inc.2,070,684$6.73M0.0%N/A2.985%Search for SEC Filing on Google Icon
2/17/2025Caxton Corp16,393$53K0.3%N/A0.024%Search for SEC Filing on Google Icon
2/14/2025Nantahala Capital Management LLC2,190,000$7.12M0.3%N/A3.157%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp64,011$0.21M0.0%N/A0.092%Search for SEC Filing on Google Icon
2/14/2025Alpine Global Management LLC14,842$48K0.0%N/A0.021%Search for SEC Filing on Google Icon
2/14/2025Stifel Financial Corp13,129$43K0.0%N/A0.019%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC84,000$0.27M0.0%N/A0.121%Search for SEC Filing on Google Icon
2/13/2025ADAR1 Capital Management LLC5,103,005$16.59M3.3%N/A7.357%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC322,878$1.05M0.0%+544.9%0.466%Search for SEC Filing on Google Icon
2/12/2025Blair William & Co. IL134,953$0.44M0.0%+7.0%0.195%Search for SEC Filing on Google Icon
8/15/2024Armistice Capital LLC589,575$0.71M0.0%N/A8.170%Search for SEC Filing on Google Icon
11/15/2023Armistice Capital LLC186,046$0.26M0.0%-62.5%3.477%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC11,455$41K0.0%N/A0.214%Search for SEC Filing on Google Icon
8/8/2023Hamilton Lane Advisors LLC13,802$50K0.0%-83.3%0.266%Search for SEC Filing on Google Icon
5/2/2023Hamilton Lane Advisors LLC82,817$54K0.0%N/A0.286%Search for SEC Filing on Google Icon
2/10/2023Blair William & Co. IL229,000$0.11M0.0%+27.9%0.817%Search for SEC Filing on Google Icon
7/12/2022Koshinski Asset Management Inc.65,377$49K0.0%N/A0.259%Search for SEC Filing on Google Icon
5/6/2022Retirement Planning Co of New England Inc.116,402$0.17M0.1%-21.0%0.461%Search for SEC Filing on Google Icon
5/5/2022Lynwood Capital Management Inc.120,000$0.18M0.2%-52.9%0.476%Search for SEC Filing on Google Icon
5/4/2022Hamilton Lane Advisors LLC165,635$0.25M0.1%N/A0.657%Search for SEC Filing on Google Icon
5/3/2022Redmond Asset Management LLC122,682$0.18M0.1%N/A0.486%Search for SEC Filing on Google Icon
2/14/2022Murchinson Ltd.220,947$0.33M0.0%-31.2%0.878%Search for SEC Filing on Google Icon
2/8/2022Retirement Planning Co of New England Inc.147,331$0.22M0.1%N/A0.586%Search for SEC Filing on Google Icon
2/3/2022ACT Capital Management LLC1,076,500$1.58M1.1%+6.6%4.279%Search for SEC Filing on Google Icon
11/16/2021ACT Capital L.L.C.1,010,000$1.92M1.0%+15.4%4.019%Search for SEC Filing on Google Icon
11/16/2021Warberg Asset Management LLC26,000$49K0.0%-71.1%0.103%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.50,741$96K0.0%+273.9%0.202%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Inhibikase Therapeutics logo
Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company, develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a non-receptor Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson's disease and gastrointestinal tract. The company is also developing IkT-001Pro, a prodrug of the anticancer agent imatinib mesylate to treat stable phase chronic myelogenous leukemia. Inhibikase Therapeutics, Inc. has research and development collaborations with Johns Hopkins University, Arizona State University, and Michigan State University; and a collaborative research and development agreement with Sphaera Pharma Pte. Ltd. The company was founded in 2008 and is headquartered in Atlanta, Georgia.
Read More on Inhibikase Therapeutics

Today's Range

Now: $1.51
Low: $1.45
High: $1.56

50 Day Range

MA: $1.56
Low: $1.41
High: $1.70

52 Week Range

Now: $1.51
Low: $1.33
High: $4.20

Volume

667,103 shs

Average Volume

190,794 shs

Market Capitalization

$113.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.88

Who are the company insiders with the largest holdings of Inhibikase Therapeutics?

Inhibikase Therapeutics' top insider investors include:
  1. Arvind Kush (Director)
Learn More about top insider investors at Inhibikase Therapeutics.

Who are the major institutional investors of Inhibikase Therapeutics?

Inhibikase Therapeutics' top institutional investors include:
  1. ADAR1 Capital Management LLC — 7.04%
  2. Vanguard Group Inc. — 4.39%
  3. Citadel Advisors LLC — 0.10%
  4. JPMorgan Chase & Co. — 0.07%
  5. New York State Common Retirement Fund — 0.06%
  6. Susquehanna International Group LLP — 0.06%
Learn More about top institutional investors of Inhibikase Therapeutics stock.

Which major investors are selling Inhibikase Therapeutics stock?

In the last quarter, IKT stock was sold by these institutional investors:
  1. Susquehanna International Group LLP
  2. New York State Common Retirement Fund

Which major investors are buying Inhibikase Therapeutics stock?

In the last quarter, IKT stock was bought by institutional investors including:
  1. ADAR1 Capital Management LLC
  2. Citadel Advisors LLC
  3. Vanguard Group Inc.
  4. JPMorgan Chase & Co.
  5. BNP Paribas Financial Markets